To verify the MSP findings and to study the extent of promoter methylation of SFRP2, we performed high-resolution bisulphite genomic sequencing in the seven cell lines, four gastric cancers with low or silenced SFRP2 expression, and in their adjacent non-cancer tissues. The gene discussed is SFRP2; the disease is cancer.